We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+3.5%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$10.8B
AUM Growth
-$222M
Cap. Flow
-$287M
Cap. Flow %
-2.66%
Top 10 Hldgs %
9.23%
Holding
920
New
57
Increased
332
Reduced
337
Closed
91

Top Buys

Rank Stock Value
1
LCII icon
LCI Industries
LCII
+$19.9M
2
KWR icon
Quaker Houghton
KWR
+$19.1M
3
FORM icon
FormFactor
FORM
+$17.5M
4
AMSF icon
AMERISAFE
AMSF
+$16.5M
5
TKR icon
Timken Company
TKR
+$16.3M

Sector Composition

Rank Sector Weight
1 Industrials 25.23%
2 Technology 19.83%
3 Financials 14.91%
4 Consumer Discretionary 12.13%
5 Healthcare 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPKI
151
NPK International
NPKI
$1.02B
$20.7M 0.19%
2,698,070
+506,518
+23% +$3.72M
AMSC icon
152
American Superconductor
AMSC
$1.29B
$20.7M 0.19%
838,932
-116,242
-12% -$3.21M
MBIN icon
153
Merchants Bancorp
MBIN
$2.49B
$20.7M 0.19%
566,245
+76,056
+16% +$3.07M
MOD icon
154
Modine Manufacturing
MOD
$9.46B
$20.6M 0.19%
177,852
-32,395
-15% -$4.17M
GENC icon
155
Gencor Industries
GENC
$212M
$20.6M 0.19%
1,166,000
+12,000
+1% +$248K
EVR icon
156
Evercore
EVR
$11.8B
$20.4M 0.19%
73,550
-27,374
-27% -$7.75M
POOL icon
157
Pool Corp
POOL
$7.05B
$20.3M 0.19%
59,624
-20
-0% -$7.29K
CAMT icon
158
Camtek
CAMT
$5.92B
$20.3M 0.19%
251,393
-398
-0.2% -$31.3K
BLFS icon
159
BioLife Solutions
BLFS
$1.54B
$20.2M 0.19%
777,282
-47,851
-6% -$1.19M
CVCO icon
160
Cavco Industries
CVCO
$4.36B
$19.7M 0.18%
44,175
-6,132
-12% -$2.82M
TPH
161
DELISTED
Tri Pointe Homes
TPH
$19.5M 0.18%
539,080
+57,559
+12% +$2.4M
HLIO icon
162
Helios Technologies
HLIO
$2.47B
$19.4M 0.18%
434,799
+46,140
+12% +$2.28M
APG icon
163
APi Group
APG
$16.7B
$19.4M 0.18%
807,192
RLI icon
164
RLI Corp
RLI
$6.02B
$18.9M 0.18%
229,100
-18,086
-7% -$1.5M
CODI icon
165
Compass Diversified
CODI
$752M
$18.9M 0.18%
817,032
-40,749
-5% -$915K
GTX icon
166
Garrett Motion
GTX
$5.39B
$18.7M 0.17%
2,072,173
+422,955
+26% +$3.51M
CAL icon
167
Caleres
CAL
$432M
$18.6M 0.17%
804,378
+172,568
+27% +$5.05M
TMDX icon
168
Transmedics
TMDX
$2.7B
$18.5M 0.17%
297,198
ATRO icon
169
Astronics
ATRO
$3.21B
$18.4M 0.17%
1,380,426
+217,943
+19% +$3.2M
TOWN icon
170
Towne Bank
TOWN
$3.54B
$18.3M 0.17%
538,053
+52,236
+11% +$1.82M
ARLO icon
171
Arlo Technologies
ARLO
$1.58B
$18.3M 0.17%
1,637,080
+229,450
+16% +$2.67M
VCTR icon
172
Victory Capital Holdings
VCTR
$6.09B
$18.2M 0.17%
278,683
+138,700
+99% +$8.78M
BANC icon
173
Banc of California
BANC
$2.87B
$18.1M 0.17%
1,172,603
-250,515
-18% -$3.95M
EXPO icon
174
Exponent
EXPO
$3.19B
$18.1M 0.17%
202,981
+15,255
+8% +$1.54M
DMLP icon
175
Dorchester Minerals
DMLP
$1.3B
$17.9M 0.17%
536,130

Similar funds

Royce & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Royce & Associates held 920 positions worth $10.8B, down 2% from $11B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

Royce & Associates's Q4 2024 filing shows 57 new, 332 increased, 337 reduced and 91 closed positions. Its largest new stake was AMERISAFE: 305,361 shares worth $15.7M. The largest sale was Ziff Davis, an estimated $33.8M.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q4 2024 buy was AMERISAFE: 305,361 shares worth $15.7M.
  • Royce & Associates added most to LCI Industries in Q4 2024, an estimated $19.9M increase.
  • Royce & Associates's biggest Q4 2024 reduction was Ziff Davis, cutting an estimated $33.8M.
  • Royce & Associates fully exited Carter's in Q4 2024, selling an estimated $13.1M.
  • Royce & Associates's ten largest holdings make up 9.2% of its $10.8B portfolio in Q4 2024.
  • Royce & Associates opened 57 new positions and closed 91 in Q4 2024.
  • Royce & Associates's portfolio value fell 2% quarter-over-quarter to $10.8B.

Based on Royce & Associates's 13F filing for Q4 2024, filed 10 Feb 2025.